Synopsis
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more info.
Episodes
-
![ASCO Lung Cancer Highlights, Part 7: Maintenance Therapy for Small Cell Lung Cancer? (audio)]()
ASCO Lung Cancer Highlights, Part 7: Maintenance Therapy for Small Cell Lung Cancer? (audio)
16/08/2013 Duration: 04minDr. David Gerber, University of Texas-Southwestern, discusses the key results and potential implications of the CALGB 30504 trial of maintenance sunitinib for extensive stage SCLC.
-
![ASCO Lung Cancer Highlights, Part 6: Predicting Benefit of Chemotherapy vs. EGFR Inhibitor Therapy in Second Line (audio)]()
ASCO Lung Cancer Highlights, Part 6: Predicting Benefit of Chemotherapy vs. EGFR Inhibitor Therapy in Second Line (audio)
16/08/2013 Duration: 06minDr. David Gerber, University of Texas-Southwestern, reviews the results of the PROSE study of the Veristrat serum proteomics test to predict benefit of chemo or EGFR inhibitor for second line treatment of advanced lung cancer.
-
![ASCO Lung Cancer Highlights, Part 5: Updates in Maintenance Therapy for Advanced NSCLC (audio)]()
ASCO Lung Cancer Highlights, Part 5: Updates in Maintenance Therapy for Advanced NSCLC (audio)
15/08/2013 Duration: 12minDr. David Gerber, University of Texas-Southwestern, discusses results of two important trials of maintenance therapy in advanced NSCLC, including the PRONOUNCE trial and POINTBREAK trials.
-
![Chemotherapy for Pancreatic Cancer, Part 1: Background and Molecular Biology (audio)]()
Chemotherapy for Pancreatic Cancer, Part 1: Background and Molecular Biology (audio)
14/08/2013 Duration: 11minDr. Colin Weekes, pancreatic cancer specialist from the University of Colorado, covers the role of chemotherapy in pancreatic cancer, beginning with the molecular biology of pancreatic cancer.
-
![ASCO Lung Cancer Highlights, Part 4: Exploring the Role of Trimodality Therapy for Stage III NSCLC (audio)]()
ASCO Lung Cancer Highlights, Part 4: Exploring the Role of Trimodality Therapy for Stage III NSCLC (audio)
14/08/2013 Duration: 06minDr. David Gerber, University of Texas-Southwestern, reviews a Swiss study comparing tri-modality therapy with chemoradiation followed by surgery to chemo followed by surgery for stage IIIA NSCLC.
-
![ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (audio)]()
ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (audio)
13/08/2013 Duration: 08minDr. David Gerber, University of Texas-Southwestern, reviews results of the START trial of tecemotide immunotherapy for stage III unresectable NSCLC.
-
![ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC (audio)]()
ASCO Lung Cancer Highlights, Part 2: Optimizing Radiation for Stage III NSCLC (audio)
11/08/2013 Duration: 08minDr. David Gerber, University of Texas-Southwestern, reviews results from RTOG 0617 that help clarify the optimal dose of radiation for stage III unresectable NSCLC.
-
![ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (audio)]()
ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (audio)
07/08/2013 Duration: 07minDr. David Gerber, University of Texas-Southwestern, reviews the current questions in managing locally advanced NSCLC with chemo/radiation as introduction to key issues addressed in trials from ASCO 2013.
-
![HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (audio)]()
HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (audio)
22/07/2013 Duration: 14minDr. Jared Weiss from the University of North Carolina, Chapel Hill reviews results from HPV-positive patients with head and neck cancer (HNSCC) from recent trials and describes emerging research in this population.
-
![HPV in Head and Neck Cancer, Part 1: What is it and What Does it Mean? (audio)]()
HPV in Head and Neck Cancer, Part 1: What is it and What Does it Mean? (audio)
22/07/2013 Duration: 07minGRACE, cancerGRACE, GRACEcast, Jared Weiss, Unveristy of North Carolina-Chapel Hill, UNC-Chapel Hill, induction therapy, neoadjuvant therapy, head and neck cancer, HNSCC, carbplatin, paclitaxel, cetuximab, Taxol, Erbitux, weekly
-
![Induction Chemotherapy for Head and Neck Cancer, Part 2: New Concepts Moving Forward (audio)]()
Induction Chemotherapy for Head and Neck Cancer, Part 2: New Concepts Moving Forward (audio)
21/07/2013 Duration: 13minDr. Jared Weiss from the University of North Carolina, reviews several options as induction therapy for head and neck cancer and focuses on the potential appeal and tolerability of the combination of weekly carboplatin and paclitaxel with cetuximab.
-
![Induction Chemotherapy for Head and Neck Cancer, Part 1: Defining the Challenges (audio)]()
Induction Chemotherapy for Head and Neck Cancer, Part 1: Defining the Challenges (audio)
18/07/2013 Duration: 09minDr. Jared Weiss from the University of North Carolina, Chapel Hill reviews the rationale for induction chemotherapy before surgery for head and neck cancer and highlights the early work that led to the emergence of the TPF regimen in this setting.
-
![Dr. Antoinette Wozniak on Small Cell Lung Cancer: Current and Future Treatments (audio)]()
Dr. Antoinette Wozniak on Small Cell Lung Cancer: Current and Future Treatments (audio)
09/06/2013 Duration: 21minDr. Antoinette (Toni) Wozniak from Karmanos Cancer Center in Detroit, MI discusses the evolution of our current best treatments for limited and extensive stage small cell lung cancer, as well as emerging potential therapies.
-
![Dr. Antoinette Wozniak on Small Cell Lung Cancer: Introduction, Diagnosis, and Staging (audio)]()
Dr. Antoinette Wozniak on Small Cell Lung Cancer: Introduction, Diagnosis, and Staging (audio)
30/05/2013 Duration: 16minDr. Antoinette (Toni) Wozniak from Karmanos Cancer Center in Detroit, MI reviews the impact, causes, common symptoms, and approach to staging of small cell lung cancer.
-
![Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 3): Evidence to Support a New, Biology-Based Staging System (audio)]()
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 3): Evidence to Support a New, Biology-Based Staging System (audio)
20/05/2013 Duration: 19minDr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews data supporting a method to define prognosis in early stage non-small cell lung cancer (NSCLC) based on molecular signatures and proposes a new staging system.
-
![Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis (audio)]()
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 2): Early Steps in Molecularly Defined Prognosis (audio)
17/05/2013 Duration: 11minDr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews early efforts in molecularly-defined staging of patients with early stage non-small cell lung cancer (NSCLC).
-
![Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 1): Potential Value of Molecular Staging (audio)]()
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 1): Potential Value of Molecular Staging (audio)
13/05/2013 Duration: 12minDr. Johannes Kratz, surgeon at Massachusetts General Hospital, explains the potential utility of molecularly guided staging of patients with early stage non-small cell lung cancer (NSCLC).
-
![Managing Pancreatic Cancer: Systemic Therapy for Localized Prostate Cancer (audio)]()
Managing Pancreatic Cancer: Systemic Therapy for Localized Prostate Cancer (audio)
04/05/2013 Duration: 08minDr. Matthew Katz, surgeon at MD Anderson Cancer Center, explains the rationale and introduces the current standards and some potential variants for systemic therapy in patients with apparently localized pancreatic cancer.
-
![Managing Pancreatic Cancer: Surgery for Pancreatic Cancer, Its Complications, and the Importance of Surgical Volume (audio)]()
Managing Pancreatic Cancer: Surgery for Pancreatic Cancer, Its Complications, and the Importance of Surgical Volume (audio)
17/04/2013 Duration: 20minDr. Matthew Katz, surgeon at MD Anderson Cancer Center, covers what surgery for pancreatic cancer entails, what the recovery process is like, and the importance of surgeon experience in outcomes.
-
![Dr. Matthew Katz: Defining Resectability of Pancreatic Cancer (audio)]()
Dr. Matthew Katz: Defining Resectability of Pancreatic Cancer (audio)
09/04/2013 Duration: 09minDr. Matthew Katz, surgeon at MD Anderson Cancer Center, discusses the factors that determine whether a person's pancreatic cancer is resectable and the importance of this factor in predicting clinical outcomes.
